Solara Active Pharma Sciences Ltd - Stock Valuation and Financial Performance

BSE: 541540 | NSE: SOLARA | Pharmaceuticals & Drugs | Small Cap

Solara Active Pharma Share Price

375 -7.20 -1.88%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Solara Active Pharma

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Solara Active Pharma Sciences stock performance -

mw4me loader
P/E Ratio (CD):
0.00
Market Cap:
1,375.8 Cr.
52-wk low:
287
52-wk high:
507.2

Is Solara Active Pharma Sciences Ltd an attractive stock to invest in?

1. Is Solara Active Pharma Sciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Solara Active Pharma Sciences Ltd is a below average quality company.

2. Is Solara Active Pharma Sciences Ltd undervalued or overvalued?

The key valuation ratios of Solara Active Pharma Sciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Solara Active Pharma Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Solara Active Pharma Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Solara Active Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Solara Active Pharma Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0%0%0%0%1.7%9.1%10%14%-0.3%1.6%-
Value Creation
Index
NANANANA-0.9-0.4-0.30-1.0-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00005211,3871,3221,6171,2681,4441,407
Sales YoY Gr.-NANANANA166.2%-4.7%22.3%-21.6%13.8%-
Adj EPS 00002.428.641.361.5-16.6-6.3-85.6
YoY Gr.-NANANANA1087.1%44.4%48.9%-127%NA-
BVPS (₹) 0000309.6329.6366.9441.1423.3416.4330.1
Adj Net
Profit
0000673.8111221-59.6-22.6-308
Cash Flow from Ops. 000049.2166242155-242156-
Debt/CF from Ops. 000012.93.22.93.9-4.26.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA22.6%3%13.8%
Adj EPS NA-221.2%-153.4%NA
BVPSNA6.1%4.3%-1.6%
Share Price - -2.2% -34.7% 10%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
00000.88.610.916.5-3.8-1.5-22.9
Op. Profit
Mgn %
00001216.619.8246.49.3-4
Net Profit
Mgn %
00001.15.38.413.7-4.7-1.6-21.9
Debt to
Equity
00000.80.60.70.40.70.7-
Working Cap
Days
00000163177178312310133
Cash Conv.
Cycle
000004064701891946

Recent Performance Summary

Debt to equity has declined versus last 3 years average to 0.67

Return on Equity is Poor

Sales growth has been subdued in last 3 years 2.99%

Sales growth is not so good in last 4 quarters at 0.23%

Latest Financials - Solara Active Pharma Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) -84.5 -85.6
TTM Sales (₹ Cr.) 1,407 1,407
BVPS (₹.) 331.3 330.1
Reserves (₹ Cr.) 1,157 1,152
P/BV 1.15 1.16
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 287.00 / 507.20
All Time Low / High (₹) 133.50 / 1859.30
Market Cap (₹ Cr.) 1,376
Equity (₹ Cr.) 36
Face Value (₹) 10
Industry PE 47.8

Management X-Ray of Solara Active Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *13.5529.4427.5127.9828.1833.7340.4639.7943.4749.06
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Solara Active Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales5211,3871,3221,6171,2681,444
Operating Expenses 4581,1661,0621,2311,1881,310
Manufacturing Costs79181172181194200
Material Costs272705599724654789
Employee Cost 69186204229236229
Other Costs 3994879610493
Operating Profit 6222125938680134
Operating Profit Margin (%) 12.0%15.9%19.6%23.9%6.3%9.3%
Other Income 21228292023
Interest 258278847590
Depreciation 348394109112111
Exceptional Items 0000-30
Profit Before Tax 668115222-91-45
Tax 0100-33-23
Profit After Tax 667115221-58-22
PAT Margin (%) 1.1%4.8%8.7%13.7%-4.6%-1.5%
Adjusted EPS (₹)0.223.142.761.6-16.2-6.2
Dividend Payout Ratio (%)0%22%5%11%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 7648499851,5851,5241,499
Share Capital 252627363636
Reserves 7398249581,5491,4881,463
Minority Interest444422
Debt573439587516893884
Long Term Debt243225233155283235
Short Term Debt330214354361610649
Trade Payables313244216309276306
Others Liabilities 167422361174195130
Total Liabilities 1,8211,9602,1532,5882,8902,821

Fixed Assets

Gross Block1,1001,3091,5811,6751,7601,868
Accumulated Depreciation36121213318429528
Net Fixed Assets1,0631,1891,3681,3561,3321,340
CWIP 71404088239238
Investments 100002
Inventories188214280295576558
Trade Receivables263289227484490537
Cash Equivalents 477657199479
Others Assets189151181166206137
Total Assets 1,8211,9602,1532,5882,8902,821

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 49166242155-242156
PBT 058115222-91-45
Adjustment 63148168173181187
Changes in Working Capital -11-25-16-206-3141
Tax Paid -3-14-24-33-1814
Cash Flow From Investing Activity -85-116-359-106-243-81
Capex -35-58-268-172-208-110
Net Investments 047-50500-1
Others -51-104-4115-3430
Cash Flow From Financing Activity 68-239792334-113
Net Proceeds from Shares 0443029830
Net Proceeds from Borrowing 532134-107169-62
Interest Paid -22-78-79-83-73-87
Dividend Paid 00-16-20-110
Others 37-11128424637
Net Cash Flow 3127-20142-151-38
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)0.788.3212.4817.23-3.75-1.47
ROCE (%)2.2210.3811.7315.34-0.671.79
Asset Turnover Ratio0.290.730.640.680.460.51
PAT to CFO Conversion(x)8.172.482.10.7N/AN/A
Working Capital Days
Receivable Days184737180140130
Inventory Days131536865125143
Payable Days420144140132163135

Solara Active Pharma Sciences Ltd Stock News

Solara Active Pharma Sciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Solara Active Pharma on 28-Mar-2024 16:01 is ₹375.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Solara Active Pharma stood at ₹1,375.8.
The latest P/E ratio of Solara Active Pharma as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Solara Active Pharma as of 28-Mar-2024 16:01 is 1.15.
The 52-week high of Solara Active Pharma is ₹507.2 and the 52-week low is ₹287.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Solara Active Pharma is ₹1,407 ( Cr.) .

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd.

The company is poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. It has hundreds of scientists working at its two R&D Centers and many API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities. 

The company has a highly compliant manufacturing footprint spread over six large scale multi-product facilities. The company’s business is spread across several countries with extensive operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. 

Business area of the company

The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies. 

Products and services
  • Commercial and R&D products
  • Contract research and Manufacturing

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.